IAM

Conviction 0HealthcareScan · Tue, Oct 20, 2026

Iambic Therapeutics, Inc. (IAM) closed at $16.01 (-2.05%) on Oct 20, 2026. -32.8% from its 52-week high, -15.4% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

IAM$16.01-2.05%

ResistanceSupportVol 14Insider buy

Oct 15Oct 16Oct 19Oct 20

Iambic Therapeutics, Inc.Biological Products, (No Diagnostic Substances)

Price16.01

Change-2.05%

Gap-3.40%

Rel volume0.01×

Avg volume1.85M

Avg $ vol37.06M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high23.81

52w low16.01

From 52w high-32.78%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)—

vs AVWAP high—

AVWAP (52w low)—

vs AVWAP low—

OBV trend—

Chaikin MF (20)—

Today vs 20d0.01×

Avg vol (14d)—

Avg vol (20d)1.85M

Avg $ vol (20d)37.06M

Market cap—

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank3.4

1 week—

1 month—

3 months—

6 months—

1 year—

YTD-15.36%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float4.18M

Float %8.8%

Short interest—

Days to cover—

Short volume64.1%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in IAM

All disclosures →

No recent disclosed trades by Congress in IAM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IAM

Insider	Side	Shares	Value	Traded	Filed
Catalio Capital Management, LP 10% owner · Series A Convertible Preferred Stock · 2026-10-16	Convert	1.14M	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Common Stock · 2026-10-16	Convert	2M	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Common Stock · 2026-10-16	Convert	1.46M	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Common Stock · 2026-10-16	Convert	742.55K	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Series B Convertible Preferred Stock · 2026-10-16	Convert	731.19K	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Series B-3 Convertible Preferred Stock · 2026-10-16	Convert	122.68K	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Series B-4 Convertible Preferred Stock · 2026-10-16	Convert	1.46M	—	2026-10-16	2026-10-19
Catalio Capital Management, LP 10% owner · Convertible Promissory Notes · 2026-10-16	Convert	742.55K	—	2026-10-16	2026-10-19
RASTETTER WILLIAM H Director · Common Stock · 2026-10-16	Convert	192.58K	—	2026-10-16	2026-10-19
RASTETTER WILLIAM H Director · Common Stock · 2026-10-16	Convert	8.34K	—	2026-10-16	2026-10-19

SEC filings

EDGAR filings in IAM · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

IAM

Recent news

Get daily signals & real-time alerts.